Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Oncology

Background:

• Curcumin, derived from Curcuma longa, offers health benefits.
• Cisplatin chemotherapy causes adverse effects and resistance.
• Cisplatin toxicity includes ototoxicity, nephrotoxicity, and neurotoxicity.

Purpose of the Study:

• To review curcumin's protective role against cisplatin toxicity.
• To summarize evidence on curcumin combating cisplatin resistance.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of research on curcumin's mechanisms of action.
• Synthesis of data on curcumin's efficacy and safety.

Main Results:

• Curcumin demonstrates protective effects against cisplatin-induced side effects.
• Curcumin shows potential in overcoming cisplatin resistance in cancer cells.
• Studies highlight curcumin's ability to mitigate ototoxicity, nephrotoxicity, and neurotoxicity.

Conclusions:

• Curcumin is a promising agent to reduce cisplatin's adverse effects.
• Curcumin may enhance cisplatin efficacy by overcoming resistance.
• Further research is warranted to explore clinical applications of curcumin in cancer therapy.